By inhibiting the NRF2-ARE activation pathway in a concentration-dependent fashion, camptothecin sensitized HCC cells to chemotherapy and anti-tumor drugs [187,188]. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.